NASDAQ : MIRM
Mirum Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 85 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.52B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Mirum Pharmaceuticals, Inc. (MIRM) reported revenue of 618.07M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 618.07M | 521.31M | 336.89M | 186.37M | 77.06M | 19.14M |
| Cost of Revenue | 112.95M | 100.24M | 81.64M | 47.04M | 12.37M | 1.90M |
| Gross Profit | 505.11M | 421.07M | 255.25M | 139.34M | 64.69M | 17.23M |
| Selling, General & Admin | 313.84M | 257.03M | 202.22M | 145.88M | 89.07M | 59.22M |
| Research & Development | 287.50M | 186.18M | 140.63M | 102.61M | 106.84M | 131.43M |
| Operating Expenses | 601.34M | 443.21M | 342.85M | 248.49M | 195.91M | 190.65M |
| Operating Income | -96.23M | -22.14M | -87.61M | -109.15M | -131.22M | -173.41M |
| Interest Expense | -13.44M | -14.39M | -14.31M | -15.11M | -15.98M | -17.59M |
| Interest & Investment Income | 13.92M | 12.73M | 13.79M | 13.73M | 3.86M | 366.00K |
| Currency Exchange Gain (Loss) | -1.10M | 700.00K | 1.20M | -1.80M | ||
| Other Non Operating Income (Expenses) | -22.96M | 1.67M | 13.00K | -1.02M | 1.27M | 106.69M |
| EBT Excluding Unusual Items | -119.80M | -21.43M | -86.91M | -113.35M | -142.07M | -83.95M |
| Other Unusual Items | -49.08M | |||||
| Pretax Income | -857.54M | -21.43M | -86.91M | -162.42M | -142.07M | -83.95M |
| Income Tax Expense | 2.67M | 1.94M | 1.03M | 991.00K | -6.41M | 37.00K |
| Net Income | -860.21M | -23.36M | -87.94M | -163.41M | -135.66M | -83.99M |
| Net Income to Common | -860.21M | -23.36M | -87.94M | -163.41M | -135.66M | -83.99M |
| Shares Outstanding (Basic) | 56.11M | 50.20M | 47.52M | 40.89M | 33.84M | 30.32M |
| Shares Outstanding (Diluted) | 56.11M | 50.20M | 47.52M | 40.89M | 33.98M | 30.32M |
| EPS (Basic) | -15.33 | -0.47 | -1.85 | -4.00 | -4.01 | -2.77 |
| EPS (Diluted) | -15.34 | -0.47 | -1.85 | -4.00 | -4.02 | -2.77 |
| Free Cash Flow | -228.74M | 54.87M | 9.33M | -71.05M | -120.41M | -132.78M |
| Free Cash Flow Per Share | -4.08 | 1.09 | 0.20 | -1.74 | -3.54 | -4.38 |
| Gross Margin | 81.73% | 80.77% | 75.77% | 74.76% | 83.94% | 90.06% |
| Operating Margin | -15.57% | -4.25% | -26.00% | -58.57% | -170.28% | -906.12% |
| Profit Margin | -139.18% | -4.48% | -26.10% | -87.68% | -176.05% | -438.86% |
| Free Cash Flow Margin | -37.01% | 10.53% | 2.77% | -38.12% | -156.26% | -693.81% |
| EBITDA | -70.28M | 2.11M | -63.98M | -98.33M | -127.98M | -172.82M |
| EBITDA Margin | -11.37% | 0.40% | -18.99% | -52.76% | -166.08% | |
| D&A For EBITDA | 25.95M | 24.24M | 23.63M | 10.83M | 3.24M | 595.00K |
| EBIT | -96.23M | -22.14M | -87.61M | -109.15M | -131.22M | -173.41M |
| EBIT Margin | -15.57% | -4.25% | -26.00% | -58.57% | -170.28% | |
| Revenue as Reported | 521.31M | 521.31M | 336.89M | 186.37M | 77.06M | 19.14M |
| Advertising Expenses | 10.90M | 11.50M | 6.30M | 4.00M | 9.20M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 330.73M | 296.68M | 222.50M | 286.33M | 28.00M | 31.34M |
| Short-Term Investments | 107.56M | 86.64M | 57.81M | 123.72M | 125.20M | |
| Cash & Short-Term Investments | 438.29M | 383.33M | 280.31M | 286.33M | 151.72M | 156.54M |
| Accounts Receivable | 145.36M | 123.33M | 78.29M | 67.97M | 23.99M | 3.27M |
| Other Receivables | 300.00K | |||||
| Receivables | 145.36M | 123.33M | 78.29M | 67.97M | 23.99M | 3.57M |
| Inventory | 25.77M | 24.89M | 22.40M | 22.31M | 5.57M | 1.51M |
| Prepaid Expenses | 26.89M | 18.14M | 11.78M | 10.94M | 8.95M | 4.97M |
| Total Current Assets | 636.31M | 549.68M | 392.79M | 387.54M | 190.22M | 166.59M |
| Property, Plant & Equipment | 14.28M | 10.60M | 9.81M | 1.99M | 2.35M | 2.55M |
| Long-Term Investments | 123.03M | 8.11M | 12.53M | 4.98M | ||
| Other Intangible Assets | 247.39M | 260.92M | 249.82M | 252.93M | 58.95M | 18.74M |
| Other Long-Term Assets | 23.98M | 13.50M | 5.81M | 4.17M | 101.38M | 101.79M |
| Total Assets | 1.04B | 842.81M | 670.75M | 646.62M | 352.91M | 294.65M |
| Accounts Payable | 23.43M | 9.61M | 14.62M | 7.42M | 8.69M | 9.17M |
| Accrued Expenses | 107.55M | 105.56M | 70.97M | 54.89M | 34.73M | 24.42M |
| Current Portion of Leases | 2.40M | 2.14M | 1.71M | 1.10M | 931.00K | 711.00K |
| Other Current Liabilities | 89.41M | 88.48M | 39.26M | 23.65M | 20.37M | 8.30M |
| Total Current Liabilities | 222.79M | 205.80M | 126.55M | 87.06M | 64.73M | 42.60M |
| Long-Term Debt | 750.08M | 309.80M | 308.08M | 306.42M | ||
| Long-Term Leases | 10.46M | 7.52M | 7.97M | 617.00K | 1.26M | 1.90M |
| Other Long-Term Liabilities | 72.07M | 5.01M | 2.51M | 3.85M | 144.88M | 129.94M |
| Total Liabilities | 1.06B | 528.12M | 445.11M | 397.95M | 210.87M | 174.44M |
| Common Stock | 6.00K | 5.00K | 5.00K | 5.00K | 4.00K | 3.00K |
| Additional Paid-In Capital | 1.52B | 981.88M | 870.19M | 803.26M | 535.07M | 377.40M |
| Retained Earnings | -1.52B | -667.54M | -644.18M | -556.24M | -392.82M | -257.16M |
| Comprehensive Income & Other | -674.00K | 351.00K | -373.00K | 1.64M | -217.00K | -35.00K |
| Total Common Equity | -10.42M | 314.69M | 225.64M | 248.67M | 142.04M | 120.21M |
| Shareholders' Equity | -10.42M | 314.69M | 225.64M | 248.67M | 142.04M | 120.21M |
| Total Liabilities & Equity | 1.04B | 842.81M | 670.75M | 646.62M | 352.91M | 294.65M |
| Total Debt | 762.95M | 319.45M | 317.76M | 308.14M | 2.19M | 2.61M |
| Net Cash (Debt) | -324.66M | 63.88M | -37.45M | -21.82M | 149.53M | 153.93M |
| Net Cash Per Share | -5.79 | 1.27 | -0.79 | -0.53 | 4.40 | 5.08 |
| Filing Date Shares Outstanding | 64.93M | 60.34M | 49.01M | 47.00M | 37.95M | 31.73M |
| Total Common Shares Outstanding | 64.75M | 51.90M | 48.34M | 46.72M | 36.96M | 30.58M |
| Working Capital | 413.52M | 343.88M | 266.24M | 300.48M | 125.50M | 124.00M |
| Book Value Per Share | -0.16 | 6.06 | 4.67 | 5.32 | 3.84 | 3.93 |
| Tangible Book Value | -257.81M | 53.77M | -24.18M | -4.25M | 83.08M | 101.47M |
| Tangible Book Value Per Share | -3.98 | 1.04 | -0.50 | -0.09 | 2.25 | 3.32 |
| Machinery | 2.16M | 1.64M | 906.00K | 600.00K | 200.00K | |
| Leasehold Improvements | 800.00K | 200.00K | 1.30M | 1.31M | 1.48M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -860.21M | -23.36M | -87.94M | -163.41M | -135.66M | -83.99M |
| Depreciation & Amortization | 25.95M | 24.24M | 23.63M | 10.83M | 3.24M | 595.00K |
| Other Amortization | 1.99M | 1.74M | 1.66M | 1.12M | ||
| Loss (Gain) From Sale of Assets | -108.00M | |||||
| Loss (Gain) From Sale of Investments | -137.00K | |||||
| Stock-Based Compensation | 103.93M | 71.42M | 48.44M | 35.02M | 27.01M | 23.09M |
| Other Operating Activities | 440.94M | 1.50M | 1.94M | 64.72M | 6.33M | 18.70M |
| Change in Accounts Receivable | -48.78M | -48.05M | -11.43M | -43.97M | -20.73M | |
| Change in Inventory | -4.97M | -8.45M | -3.17M | -974.00K | -3.45M | -495.00K |
| Change in Accounts Payable | 65.97M | 50.10M | 40.31M | 30.78M | 7.64M | 22.66M |
| Change in Other Net Operating Assets | 47.91M | -13.31M | -3.13M | -5.05M | -4.51M | -5.18M |
| Operating Cash Flow | -227.27M | 55.83M | 10.32M | -70.94M | -120.14M | -132.76M |
| Capital Expenditures | -1.47M | -954.00K | -993.00K | -109.00K | -278.00K | -24.00K |
| Cash Acquisitions | -212.76M | |||||
| Sale (Purchase) of Intangibles | -35.00M | -20.00M | -20.00M | -19.00M | ||
| Investment in Securities | -136.31M | -23.00M | -69.13M | 125.67M | 7.98M | -40.43M |
| Other Investing Activities | 108.00M | |||||
| Investing Cash Flow | -172.78M | -23.95M | -90.12M | -107.20M | 7.70M | 48.55M |
| Long-Term Debt Issued | 305.30M | |||||
| Total Debt Issued | 672.43M | 305.30M | ||||
| Net Debt Issued (Repaid) | 672.43M | 305.30M | ||||
| Issuance of Common Stock | 308.54M | 40.14M | 17.70M | 227.15M | 114.64M | 9.01M |
| Other Financing Activities | -195.86M | -5.55M | 64.45M | |||
| Financing Cash Flow | 506.61M | 40.14M | 17.70M | 336.60M | 109.09M | 73.47M |
| Foreign Exchange Rate Adjustments | -2.70M | 3.22M | -1.30M | -133.00K | 12.00K | -1.00K |
| Net Cash Flow | 103.86M | 75.24M | -63.40M | 158.32M | -3.34M | -10.75M |
| Free Cash Flow | -228.74M | 54.87M | 9.33M | -71.05M | -120.41M | -132.78M |
| Free Cash Flow Margin | -37.01% | 10.53% | 2.77% | -38.12% | -156.26% | -693.81% |
| Free Cash Flow Per Share | -4.08 | 1.09 | 0.20 | -1.74 | -3.54 | -4.38 |
| Levered Free Cash Flow | 76.62M | 98.56M | 16.67M | -91.35M | -68.57M | -96.18M |
| Unlevered Free Cash Flow | 83.03M | 105.81M | 23.95M | -83.03M | -58.59M | -85.19M |
| Cash Interest Paid | 13.03M | 12.65M | 12.65M | 6.82M | ||
| Cash Income Tax Paid | 1.64M | 2.16M | 1.00M | 125.00K | ||
| Change in Working Capital | 60.14M | -19.71M | 22.59M | -19.22M | -21.05M | 16.98M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 5.52B | 4.08B | 1.98B | 1.38B | 718.54M | 486.19M |
| Enterprise Value | 5.84B | 4.03B | 2.02B | 1.38B | 535.28M | 298.94M |
| Last Close Price | 85.00 | 78.99 | 41.35 | 29.52 | 19.50 | 15.95 |
| PS Ratio | 8.93 | 7.83 | 5.89 | 7.38 | 9.32 | 25.41 |
| PB Ratio | 12.97 | 8.80 | 5.53 | 5.06 | 4.04 | |
| P/TBV Ratio | 75.93 | 8.65 | 4.79 | |||
| P/FCF Ratio | 74.40 | 212.71 | ||||
| P/OCF Ratio | 73.13 | 192.25 | ||||
| EV/Sales Ratio | 9.46 | 7.72 | 5.99 | 7.39 | 6.95 | 15.62 |
| EV/EBITDA Ratio | 1,909.73 | |||||
| EV/FCF Ratio | 73.36 | 216.27 | ||||
| Debt / Equity Ratio | -73.21 | 1.01 | 1.41 | 1.24 | 0.01 | 0.02 |
| Debt / EBITDA Ratio | 70.86 | |||||
| Debt / FCF Ratio | 5.82 | 34.05 | ||||
| Net Debt / Equity Ratio | -31.15 | -0.20 | 0.17 | 0.09 | -1.05 | -1.28 |
| Net Debt / EBITDA Ratio | -4.62 | -30.30 | -0.58 | -0.22 | 1.17 | 0.89 |
| Net Debt / FCF Ratio | -1.42 | -1.16 | 4.01 | -0.31 | 1.24 | 1.16 |
| Asset Turnover | 0.70 | 0.69 | 0.51 | 0.37 | 0.24 | 0.07 |
| Inventory Turnover | 4.64 | 4.24 | 3.65 | 3.38 | 3.50 | |
| Quick Ratio | 2.62 | 2.46 | 2.83 | 4.07 | 2.71 | 3.76 |
| Current Ratio | 2.86 | 2.67 | 3.10 | 4.45 | 2.94 | 3.91 |
| Return on Equity (ROE) | -702.97% | -8.65% | -37.08% | -83.65% | -103.46% | -57.47% |
| Return on Assets (ROA) | -6.79% | -1.83% | -8.31% | -13.65% | -25.33% | -40.48% |
| Return on Capital Employed (ROCE) | -11.70% | -3.50% | -16.10% | -19.50% | -45.50% | -68.80% |
| Earnings Yield | -18.04% | -0.57% | -4.43% | -11.88% | -18.88% | -17.27% |
| FCF Yield | -4.14% | 1.34% | 0.47% | -5.16% | -16.76% | -27.31% |
| Buyback Yield / Dilution | -15.36% | -5.63% | -16.23% | -20.31% | -12.07% | -20.08% |